Lara Sullivan

Insider Reports History

Location
Rockville, MD
Signature
/s/ Pamela Connealy, Attorney-in-Fact for Lara Sullivan
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Lara Sullivan:

Company Role Class Num Shares Value Price $ Report Date Ownership
Pyxis Oncology, Inc. President ,CEO & CMO, Director Stock Option (Right to Buy) 918,308 $899,942 $0.9800 31 Mar 2025 Direct

Insider Reports Filed by Lara Sullivan

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PYXS Pyxis Oncology, Inc. 31 Mar 2025 1 +$899,942 4 President ,CEO & CMO, Director 02 Apr 2025, 09:06
PYXS Pyxis Oncology, Inc. 23 Dec 2024 1 $0 4 Chief Executive Officer, Director 23 Dec 2024, 16:33
PYXS Pyxis Oncology, Inc. 26 Mar 2024 1 +$4,102,857 4 Chief Executive Officer, Director 28 Mar 2024, 16:33
PYXS Pyxis Oncology, Inc. 14 Sep 2023 2 -$18,161 4 President and CEO, Director 18 Sep 2023, 19:03
PYXS Pyxis Oncology, Inc. 11 Sep 2023 4 -$456,801 4 President and CEO, Director 13 Sep 2023, 20:16
PYXS Pyxis Oncology, Inc. 07 Sep 2023 1 $0 4 President and CEO, Director 08 Sep 2023, 17:00
PYXS Pyxis Oncology, Inc. 24 Mar 2023 5 $0 4 President and CEO, Director 28 Mar 2023, 16:48
PYXS Pyxis Oncology, Inc. 03 Jan 2023 1 $0 4 Chief Executive Officer, Director 03 Jan 2023, 18:39
PYXS Pyxis Oncology, Inc. 14 Apr 2022 1 $0 4 Chief Executive Officer, Director 15 Apr 2022, 19:56
PYXS Pyxis Oncology, Inc. 31 Mar 2022 1 $0 4 Chief Executive Officer, Director 04 Apr 2022, 16:15
PYXS Pyxis Oncology, Inc. 07 Oct 2021 1 $0 4 Chief Executive Officer, Director 12 Oct 2021, 19:47
PYXS Pyxis Oncology, Inc. 07 Oct 2021 0 $0 3 Chief Executive Officer, Director 07 Oct 2021, 21:28